Despite significant insider shares, Milestone Pharmaceutical...
Despite significant insider shares, Milestone Pharmaceuticals noted fairly low insider ownership. The absence of recent insider transactions is raising concerns. It's more encouraging if insiders bought more shares in the company.
Milestone Pharmaceuticals Insiders Lose Out As Stock Sinks To US$1.67
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment